Pneumococcal Vaccine: Another Vaccine Success
The Study: The pneumonia rate in Nicaragua was calculated before and after adding the 13-valent pneumococcal conjugate vaccine to their routine vaccination schedule. The vaccine was given at two, four and six months of age.
The Results: The rates of outpatient visits and hospitalizations for all types of pneumonia decreased by a third after the vaccine addition. Infant mortality rates from all causes also decreased by about a third.
Comment: It’s estimated that more than two million children die each year worldwide from pneumonia. That’s more than from AIDS, malaria and measles combined. Any vaccine that helps prevent pneumonia should be used universally.
Read More: The Pediatric Infectious Disease Journal, 06/14
You may also be interested in:
Sagall, R. (2015). Pneumococcal Vaccine: Another Vaccine Success. Pediatrics for Parents. Retrieved on September 21, 2017, from http://www.pedsforparents.com/vaccinations-2/104163/pneumococcal-vaccine-another-vaccine-success/